missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EEF1D (aa 74-169) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (80%), Rat (80%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-111323 (PA5-111323. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This subunit functions as guanine nucleotide exchange factor. It is reported that this subunit interacts with HIV-1 Tat, and thus it represses the translation of host-cell, but not HIV-1, mRNAs. Several alternatively spliced transcript variants encoding multiple isoforms have been found for this gene.
Specifications
Specifications
| Accession Number | P29692 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 1936 |
| Name | Human EEF1D (aa 74-169) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | antigen NY-CO-4; EEF 1 D; Eef1d; EF 1 delta; EF 1 D; EF1D; EF-1 D; EF-1-delta; Elongation factor 1-delta; eukaryotic translation elongation factor 1 delta; eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein); FP1047; guanine nucleotide exchange protein; translation elongation factor 1-delta subunit |
| Common Name | EEF1D |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction